AlloDx Presents Products and Research at CSOT 2018

The 2018 Organ Transplantation Annual Conference of the Chinese Medical Association was held from October 26 to 28, 2018, at the Yanqi Lake International Convention and Exhibition Center in Beijing.

The company presented four latest research achievements in the transplantation liquid biopsy field at the conference and was invited, together with partner institutions, to deliver keynote reports. Among them, the project report 'Application of dd-cfDNA in the diagnosis of acute rejection and evaluation of treatment efficacy after kidney transplantation' represented an early domestic research achievement in the direction of non-invasive rejection detection, providing a technical platform and data support for the application of non-invasive rejection detection in the Chinese transplant patient population. The three other research achievements—'high-throughput pathogenic microorganism detection platform,' 'early post-transplant dd-cfDNA concentration dynamic monitoring,' and 'establishment of a dd-cfDNA quantitative model independent of donor genotype'—were also presented as data reports in the transplantation pathology and transplantation infection sub-sessions, receiving active attention and unanimous recognition from the participating experts.

The Annual Academic Congress of the Chinese Society of Organ Transplantation and the Annual Congress of Chinese Transplant Physicians are influential organ transplantation academic organizations in China. The CSOT Annual Congress of Organ Transplantation is a high-level national academic event in Chinese organ transplantation, and each meeting is a stage for elites across the transplantation field to showcase their expertise.

AlloDx focuses on the rehabilitation market after organ transplantation. Since its founding, the team has been deeply engaged in transplant rejection and pathogenic infection testing, and has preliminarily built a Chinese transplant-population rejection and pathogenic-infection database. To actively exchange research results with renowned domestic transplant experts and peers, Dr. Ge Jun, Marketing Director, led the marketing and medical teams along with nearly ten people including Professor Zhou Yang from the Jiangsu University Institute of Organ Transplantation to the CSOT event.

The 2018 CSOT conference has come to an end, and the fruitful results guide us on a new journey. It is believed that in the near future, through accurate diagnosis, transplant patients will have longer quality of life and survival after surgery, and clinical treatments will be more accurate and effective. We have been working hard for the happiness of organ transplant patients and their families!